The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood

被引:1129
作者
Aiuti, A
Webb, IJ
Bleul, C
Springer, T
GutierrezRamos, JC
机构
[1] MULLENIUM PHARMACEUT INC, CAMBRIDGE, MA 02139 USA
[2] CTR BLOOD RES INC, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA
[4] HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA
[5] HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA
[6] DANA FARBER CANC INST, BLOOD COMPONENT LAB, BOSTON, MA 02115 USA
关键词
D O I
10.1084/jem.185.1.111
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hematopoietic progenitor cells migrate in vitro and in vivo towards a gradient of the chemotactic factor stromal cell-derived factor-1 (SDF-1) produced by stromal cells. This is the first chemoattractant reported for human CD34(+) progenitor cells. Concentrations of SDF-1 that elicit chemotaxis also induce a transient elevation of cytoplasmic calcium in CD34(+) cells. SDF-1-induced chemotaxis is inhibited by pertussis toxin, suggesting that its signaling in CD34(+) cells is mediated by seven transmembrane receptors coupled to G(i) proteins. CD34(+) cells migrating to SDF-1 include cells with a more primitive (CD34(+)/CD38(-) or CD34(+)/DR(-)) phenotype as well as CD34(+) cells phenotypically committed to the erythroid, lymphoid and myeloid lineages, including functional BFU-E, CFU-GM, and CFU-MIX progenitors. Chemotaxis of CD34(+) cells in response to SDF-1 is increased by IL-3 in vitro and is lower in CD34(+) progenitors from peripheral blood than in CD34(+) progenitors from bone marrow, suggesting that an altered response to SDF-1 may be associated with CD34 progenitor mobilization.
引用
收藏
页码:111 / 120
页数:10
相关论文
共 57 条
[11]  
GIANNI AM, 1989, LANCET, V2, P580
[12]  
GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702
[13]   IDENTIFICATION AND CHARACTERIZATION OF AN INHIBITOR OF HEMATOPOIETIC STEM-CELL PROLIFERATION [J].
GRAHAM, GJ ;
WRIGHT, EG ;
HEWICK, R ;
WOLPE, SD ;
WILKIE, NM ;
DONALDSON, D ;
LORIMORE, S ;
PRAGNELL, IB .
NATURE, 1990, 344 (6265) :442-444
[14]   IL-3 AND PERIPHERAL-BLOOD STEM-CELL HARVESTING [J].
GUILLAUME, T ;
DHONDT, V ;
SYMANN, M .
STEM CELLS, 1993, 11 (03) :173-181
[15]   5 TUMOR NECROSIS FACTOR-INDUCIBLE CELL-ADHESION MECHANISMS ON THE SURFACE OF MOUSE ENDOTHELIOMA CELLS MEDIATE THE BINDING OF LEUKOCYTES [J].
HAHNE, M ;
JAGER, U ;
ISENMANN, S ;
HALLMANN, R ;
VESTWEBER, D .
JOURNAL OF CELL BIOLOGY, 1993, 121 (03) :655-664
[16]  
HAYLOCK DN, 1992, BLOOD, V80, P1405
[17]  
HEALY LE, 1994, EXP HEMATOL, V22, P1278
[18]   MAINTENANCE OF TRANSPLANTATION POTENTIAL IN EX-VIVO EXPANDED CD34(+)-SELECTED HUMAN PERIPHERAL-BLOOD PROGENITOR CELLS [J].
HENSCHLER, R ;
BRUGGER, W ;
LUFT, T ;
FREY, T ;
MERTELSMANN, R ;
KANZ, L .
BLOOD, 1994, 84 (09) :2898-2903
[19]   LYMPHOID AND MYELOID DIFFERENTIATION OF SINGLE HUMAN CD34(+), HLA-DR(+), CD38(-) HEMATOPOIETIC STEM-CELLS [J].
HUANG, S ;
TERSTAPPEN, LWMM .
BLOOD, 1994, 83 (06) :1515-1526
[20]  
ITOH K, 1989, EXP HEMATOL, V17, P145